PlenadrEMA study - Effect of modified-release compared to conventional hydrocortisone on fatigue, measured by Ecological Momentary Assessments; a pilot study to assess feasibility, responsiveness of outcomes and to inform power calculations for future large-scale RCTs

Trial Profile

PlenadrEMA study - Effect of modified-release compared to conventional hydrocortisone on fatigue, measured by Ecological Momentary Assessments; a pilot study to assess feasibility, responsiveness of outcomes and to inform power calculations for future large-scale RCTs

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 May 2017

At a glance

  • Drugs Hydrocortisone (Primary)
  • Indications Adrenal insufficiency; Fatigue
  • Focus Therapeutic Use
  • Acronyms PlenadrEMA
  • Most Recent Events

    • 04 Apr 2016 Planned End Date changed from 2 Nov 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
    • 04 Apr 2016 Planned primary completion date changed from 1 Nov 2015 to 1 Nov 2017 as reported by ClinicalTrials.gov record.
    • 01 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top